Michaelis, Sophie

[["dc.bibliographiccitation.firstpage","333"],["dc.bibliographiccitation.issue","6"],["dc.bibliographiccitation.journal","The British Journal of Psychiatry"],["dc.bibliographiccitation.lastpage","338"],["dc.bibliographiccitation.volume","212"],["dc.contributor.author","Bandelow, Borwin"],["dc.contributor.author","Sagebiel, Anne"],["dc.contributor.author","Belz, Michael"],["dc.contributor.author","Görlich, Yvonne"],["dc.contributor.author","Michaelis, Sophie"],["dc.contributor.author","Wedekind, Dirk"],["dc.date.accessioned","2020-12-10T18:41:28Z"],["dc.date.available","2020-12-10T18:41:28Z"],["dc.date.issued","2018"],["dc.identifier.doi","10.1192/bjp.2018.49"],["dc.identifier.eissn","1472-1465"],["dc.identifier.issn","0007-1250"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/77588"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Enduring effects of psychological treatments for anxiety disorders: meta-analysis of follow-up studies"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","53"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","British Journal of Psychiatry"],["dc.bibliographiccitation.lastpage","54"],["dc.bibliographiccitation.volume","214"],["dc.contributor.author","Bandelow, Borwin"],["dc.contributor.author","Sagebiel, Anne"],["dc.contributor.author","Belz, Michael"],["dc.contributor.author","Görlich, Yvonne"],["dc.contributor.author","Michaelis, Sophie"],["dc.contributor.author","Wedekind, Dirk"],["dc.date.accessioned","2020-12-10T18:41:27Z"],["dc.date.available","2020-12-10T18:41:27Z"],["dc.date.issued","2018"],["dc.identifier.doi","10.1192/bjp.2018.226"],["dc.identifier.eissn","1472-1465"],["dc.identifier.issn","0007-1250"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/77587"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Authors' reply"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","183"],["dc.bibliographiccitation.issue","4"],["dc.bibliographiccitation.journal","International Clinical Psychopharmacology"],["dc.bibliographiccitation.lastpage","192"],["dc.bibliographiccitation.volume","30"],["dc.contributor.author","Bandelow, Borwin"],["dc.contributor.author","Reitt, Markus"],["dc.contributor.author","Roever, Christian"],["dc.contributor.author","Michaelis, Sophie"],["dc.contributor.author","Goerlich, Yvonne"],["dc.contributor.author","Wedekind, Dirk"],["dc.date.accessioned","2018-11-07T09:55:22Z"],["dc.date.available","2018-11-07T09:55:22Z"],["dc.date.issued","2015"],["dc.description.abstract","To our knowledge, no previous meta-analysis has attempted to compare the efficacy of pharmacological, psychological and combined treatments for the three main anxiety disorders (panic disorder, generalized anxiety disorder and social phobia). Pre-post and treated versus control effect sizes (ES) were calculated for all evaluable randomized-controlled studies (n=234), involving 37333 patients. Medications were associated with a significantly higher average pre-post ES [Cohen's d=2.02 (1.90-2.15); 28051 patients] than psychotherapies [1.22 (1.14-1.30); 6992 patients; P<0.0001]. ES were 2.25 for serotonin-noradrenaline reuptake inhibitors (n=23 study arms), 2.15 for benzodiazepines (n=42), 2.09 for selective serotonin reuptake inhibitors (n=62) and 1.83 for tricyclic antidepressants (n=15). ES for psychotherapies were mindfulness therapies, 1.56 (n=4); relaxation, 1.36 (n=17); individual cognitive behavioural/exposure therapy (CBT), 1.30 (n=93); group CBT, 1.22 (n=18); psychodynamic therapy 1.17 (n=5); therapies without face-to-face contact (e.g. Internet therapies), 1.11 (n=34); eye movement desensitization reprocessing, 1.03 (n=3); and interpersonal therapy 0.78 (n=4). The ES was 2.12 (n=16) for CBT/drug combinations. Exercise had an ES of 1.23 (n=3). For control groups, ES were 1.29 for placebo pills (n=111), 0.83 for psychological placebos (n=16) and 0.20 for waitlists (n=50). In direct comparisons with control groups, all investigated drugs, except for citalopram, opipramol and moclobemide, were significantly more effective than placebo. Individual CBT was more effective than waiting list, psychological placebo and pill placebo. When looking at the average pre-post ES, medications were more effective than psychotherapies. Pre-post ES for psychotherapies did not differ from pill placebos; this finding cannot be explained by heterogeneity, publication bias or allegiance effects. However, the decision on whether to choose psychotherapy, medications or a combination of the two should be left to the patient as drugs may have side effects, interactions and contraindications."],["dc.identifier.doi","10.1097/YIC.0000000000000078"],["dc.identifier.isi","000356371200002"],["dc.identifier.pmid","25932596"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/36722"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Lippincott Williams & Wilkins"],["dc.relation.issn","1473-5857"],["dc.relation.issn","0268-1315"],["dc.title","Efficacy of treatments for anxiety disorders: a meta-analysis"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","327"],["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","DIALOGUES IN CLINICAL NEUROSCIENCE"],["dc.bibliographiccitation.lastpage","335"],["dc.bibliographiccitation.volume","17"],["dc.contributor.author","Bandelow, Borwin"],["dc.contributor.author","Michaelis, Sophie"],["dc.date.accessioned","2018-11-07T09:52:56Z"],["dc.date.available","2018-11-07T09:52:56Z"],["dc.date.issued","2015"],["dc.description.abstract","Anxiety disorders, including panic disorder with or without agoraphobia, generalized anxiety disorder, social anxiety disorder, specific phobias, and separation anxiety disorder, are the most prevalent mental disorders and are associated with immense health care costs and a high burden of disease. According to large populationbased surveys, up to 33.7% of the population are affected by an anxiety disorder during their lifetime. Substantial underrecognition and undertreatment of these disorders have been demonstrated. There is no evidence that the prevalence rates of anxiety disorders have changed in the past years. In cross-cultural comparisons, prevalence rates are highly variable. It is more likely that this heterogeneity is due to differences in methodology than to cultural influences. Anxiety disorders follow a chronic course; however, there is a natural decrease in prevalence rates with older age. Anxiety disorders are highly comorbid with other anxiety disorders and other mental disorders."],["dc.identifier.isi","000390189900009"],["dc.identifier.pmid","26487813"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/36228"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Inst Conference Hippocrate"],["dc.relation.issn","1958-5969"],["dc.relation.issn","1294-8322"],["dc.title","Epidemiology of anxiety disorders in the 21st century"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]